You are viewing the site in preview mode

Skip to content

Advertisement

  • Case report
  • Open Access

Carcinosarcoma of the parotid gland with abdominal metastasis: a case report and review of literature

World Journal of Surgical Oncology201816:103

https://doi.org/10.1186/s12957-018-1406-6

  • Received: 7 March 2018
  • Accepted: 28 May 2018
  • Published:

Abstract

Background

Carcinosarcoma of the salivary gland is a rare aggressive malignant tumor, composed of a mixture of carcinomatous and sarcomatous components. The most common metastatic sites include the lungs, bones, and central nervous system.

Case presentation

This report describes a rare case of carcinosarcoma of the parotid gland with an osteosarcoma as sarcomatous component in a 72-year-old man who had a history of low anterior resection for rectal cancer. Six months after parotidectomy, he presented abdominal pain as a symptom of abdominal metastasis by the sarcomatous component. At that time, the possibility of abdominal metastasis was overlooked because of the history of abdominal surgery. After several days of conservative treatment, emergency laparotomy was done. However, he died of acute respiratory distress syndrome.

Conclusions

Awareness of the possibility of abdominal metastasis by salivary carcinosarcoma may help in managing patients with a history of abdominal surgery.

Keywords

  • Carcinosarcoma
  • Parotid gland
  • Metastasis
  • Osteosarcoma
  • Abdominal cavity

Background

Carcinosarcoma, also called true malignant mixed tumor, is an aggressive malignant neoplasm of the salivary gland. It is an extremely rare malignancy, comprising 0.04 to 0.16% of all salivary gland tumors and 0.4% of all malignant salivary gland neoplasms. The mean age at presentation is in the sixth to seventh decade of life, but can range from 14 to 87 years [13]. Although de novo carcinosarcomas can occur in the salivary gland, many patients have a history of long standing or recurrent pleomorphic adenomas, a condition described as carcinosarcoma ex pleomorphic adenoma [46]. Most of these lesions arise in the major salivary glands, with two thirds in the parotid glands [2]. Patients typically present with a rapidly growing mass.

These tumors are composed of a mixture of distinct carcinomatous and sarcomatous components with either component capable of metastasis. Malignant epithelial components of salivary gland carcinosarcomas include squamous cell carcinoma and adenocarcinoma, whereas malignant mesenchymal components include chondrosarcoma, fibrosarcoma, leiomyosarcoma, osteosarcoma, and liposarcoma, in that order of frequency [1]. The most common metastatic sites include the lungs, bones, and central nervous system [24].

To date, 10 cases of carcinosarcoma of salivary glands with osteosarcomatous element have been published, of which only lung metastasis have been found [716]. We describe a case of carcinosarcoma arising in the parotid gland with an osteosarcomatous component which metastasized to abdominal cavity; to our knowledge, this is the first patient so described.

Case presentation

A 72-year-old man presented with a mass in the right parotid area that had become rapidly enlarged for 2 months. His medical history included a subtotal gastrectomy for a gastric ulcer 20 years earlier and low anterior resection for moderately differentiated adenocarcinoma of the rectum (Stage T1N0) 1 year earlier. Preoperative computed tomography (CT) showed a relatively well-defined heterogeneous enhancing solid lesion with calcification in the superficial lobe of the right parotid gland, with no indications of metastasis to the regional lymph nodes (Fig. 1).
Fig. 1
Fig. 1

A heterogeneous enhancing solid lesion with calcification (arrow) was identified in the superficial lobe of right parotid gland on neck CT

Fine-needle aspiration specimen showed that the tumor contained many clusters of malignant epithelial cells and scattered atypical spindle cells on a necrotic background. Under suspicion of a malignant tumor, the patient underwent total parotidectomy. Gross examination of the specimen revealed a multifocal, ill-defined, grayish-white, and heterogeneous solid tumor, accompanied by calcification and measuring 3 × 2.5 cm. Microscopically, the tumor was composed of two malignant components, carcinoma (Fig. 2a, b) and sarcoma (Fig. 2c), with multifocal invasion (> 1.5 mm) of the capsule and adjacent tissues on a background of pre-existing pleomorphic adenoma (Fig. 2d). The carcinoma component of the tumor consisted of squamous cell carcinoma and poorly differentiated adenocarcinoma, whereas the sarcoma component consisted mainly of osteosarcoma, characterized by neoplastic bone and severe cellular anaplasia. Many mitotic figures and necrotic foci were observed. The external resection margin showed tumor involvement. Immunohistochemical staining showed that the carcinoma cells were positive for cytokeratin AE1/AE3 (Fig. 3a) and the osteosarcoma component was diffusely positive for vimentin (Fig. 3b). Both components showed some degree of nuclear immunoreactivity for p53 (Fig. 3c, d).
Fig. 2
Fig. 2

a The tumor cells showed features of squamous cell carcinoma, which were composed of abundant pink cytoplasm, moderate atypia, and focal keratinization (magnification, × 100). b The poorly differentiated adenocarcinoma components were consisted of solid nests of poorly differentiated tumor cells with ovoid nuclei and prominent nucleoli (magnification, × 100). c The sarcoma component consisted mainly of osteosarcoma, characterized by neoplastic bone and severe cellular anaplasia (magnification, × 100). d In pleomorphic adenoma component, the tubular and acinar structures formed by epithelial cells were compressed by abundant hyalinized eosinophilic matrix (magnification, × 100)

Fig. 3
Fig. 3

Immunohistochemistry showed that carcinomatous components were positive for cytokeratin AE1/AE3 (a) and sarcomatous components were positive for vimentin (b). Both components showed some degree of nuclear immunoreactivity for p53 (c carcinoma component; d sarcoma component) (magnification, all × 100)

Following surgery, the patient received postoperative radiation therapy. Six months later, he complained of abdominal pain. Abdominal CT showed a distension of small bowel with luminal narrowing and localized high density material in the abdominal cavity (Fig. 4). The lesion was regarded as mechanical obstruction with postoperative adhesion because the patient had undergone previous abdominal surgery for rectal adenocarcinoma. After conservative management for several days, he experienced severe abdominal pain and an increased heart rate, and an emergency laparotomy was performed. Multiple hard calcified masses were observed in the abdominal walls, omentum, and mesentery, and mass excision with small bowel resection was done. On gross examination, bulky, gritty, and hemorrhagic mass adhered to the mesentery was identified (Fig. 5). Microscopically, the tumors were identified as osteogenic sarcomas, with histologic features identical to those of the osteosarcomatous component of the carcinosarcoma of the parotid gland (Fig. 6a). The tumor cells were positive for vimentin on immunohistochemical staining (Fig. 6b). Because of its rapid development over 6 months and no history of osteosarcoma at any sites, we concluded that the abdominal osteosarcoma was metastatic from the carcinosarcoma of the parotid gland. The patient was postoperatively admitted to the intensive care unit and died of acute respiratory distress syndrome (ARDS) caused by aspiration pneumonia.
Fig. 4
Fig. 4

A localized high density material (arrow) in the abdominal cavity was presented in abdominal CT

Fig. 5
Fig. 5

Bulky, gritty, and hemorrhagic masses (arrow) adhered to the small intestinal mesentery were observed

Fig. 6
Fig. 6

a Microscopically, the abdominal mass showed the osteosarcoma (magnification, × 100). b The immunostaining for vimentin was diffuse positive (magnification, × 100)

Discussion and conclusions

Malignant mixed tumors of the salivary gland can describe three distinct histologic entities: carcinoma ex pleomorphic adenoma (the most common), metastasizing mixed tumor, and carcinosarcoma [1]. More than 99% of these tumors arise from pleomorphic adenomas, with only 0.2% being primary carcinosarcomas or true malignant mixed tumors [17]. Two hypotheses have been advanced to explain the histogenesis of carcinosarcoma. The convergence hypothesis suggests that these tumors are multiclonal and are derived from two or more types of mesenchymal and epithelial stem cells. The divergence hypothesis suggests that these tumors are monoclonal, with a single totipotent stem cell differentiating into epithelial and mesenchymal cells [18].

Surgery followed by radiation therapy may aid in the treatment of salivary carcinosarcoma. Despite treatment, over half of these patients die of local recurrence and/or metastasis and the average survival of these patients is 3.6 years [2, 7].

Only 10 cases of carcinosarcoma with osteosarcoma as the sarcomatous component have been reported. The clinicopathological features and outcomes of the reported cases are detailed in Table 1. Our reviews exhibited a male predominance (72.7%) with an age range of 35 to 83 years (median, 64 years). All cases had an adenocarcinoma as the carcinomatous component, and three cases also showed squamous cell carcinoma elements. The sarcomatous components other than osteosarcoma were chondrosarcomas, rhabdomyosarcomas, and fibrosarcomas. Of the 11 cases, 8 cases occurred in the parotid gland. All patients underwent surgical resection and 6 of them received radiotherapy and/or chemotherapy. Distant metastasis occurred in five cases, of which four cases involved the lung. In the present case, the sarcomatous component was an osteosarcoma, and the carcinomatous components were adenocarcinoma and squamous cell carcinoma. The tumor metastasized to the abdominal cavity by the osteosarcomatous component alone, which has not been reported to date.
Table 1

Review of previously reported cases of carcinosarcoma of the salivary glands with osteosarcoma components

Reference

Age (years)/sex

Location

Histologic type of carcinoma

Histologic type of sarcoma

Metastasis/site

Histologic type of metastatic tumor

Treatment

Outcome

Garner et al. 1989 [7]

57/F

Parotid gland

Adenocarcinoma

Osteosarcoma, chondrosarcoma

No

(−)

Left parotidectomy and radical neck dissection

Local recurrence at 6 weeks and died

Yamashita et al. 1990 [8]

52/M

Submandibular gland

Adenocarcinoma, squamous cell carcinoma

Osteosarcoma, chondrosarcoma, fibrosarcoma

No

(−)

Excision and right modified neck dissection with chemotherapy

No recurrence for 5 months

Bleiweiss et al. 1992 [9]

64/M

Submandibular gland

Adenocarcinoma

Osteosarcoma

No

(−)

Partial mandibulectomy with radical neck dissection

Local recurrence at 4 months

de la Torre et al. 1995 [10]

83/F

Parotid gland

Adenocarcinoma

Osteosarcoma, chondrosarcoma

Yes/lung

NR

Wide excision

Local recurrence and lung metastasis, died after 1 year

Carson et al. 1995 [11]

51/F

Parotid gland

Adenocarcinoma

Osteosarcoma

No

(−)

Total parotidectomy with chemotherapy

Local recurrence at 7 months and died at 9 months

Gogas et al. 1999 [12]

77/M

Submandibular gland

Salivary duct carcinoma

Osteosarcoma. chondrosarcoma, rhabdomyosarcoma

Yes/lung

NR

Wide excision with radiotherapy and chemotherapy

Lung metastasis at 3 months

Sironi et al. 2000 [13]

77/M

Parotid gland

Squamous cell carcinoma, adenocarcinoma,

Osteosarcoma

Yes/NR

NR

Right total parotidectomy with radical neck dissection

Metastasis at 3 months

Mardi et al. 2004 [14]

59/M

Parotid gland

Adenocarcinoma

Osteosarcoma, chondrosarcoma

NA

NA

NA

NA

Jang et al. 2011 [15]

67/M

Parotid gland

Adenocarcinoma

Osteosarcoma

Yes/lung

Osteosarcoma

Left parotidectomy with radiotherapy

Lung metastasis at 5 months

Jha et al.2017 [16]

35/M

Parotid gland

Adenocarcinoma

Osteosarcoma

No

(−)

Total radical parotidectomy with radiotherapy

No recurrence for 12 months

Present case

72/M

Parotid gland

Adenocarcinoma, squamous cell carcinoma

Osteosarcoma

Yes/abdominal cavity

Osteosarcoma

Total parotidectomy with radiotherapy

Metastasis at 6 months and died

NA, not available, NR not reported

The present patient underwent surgery and adjuvant radiotherapy. After 6 months, he complained of abdominal pain. At that time, the signs of small bowel obstruction with high density material in the abdominal cavity found on CT were regarded as an effect of his abdominal surgery for rectal adenocarcinoma 1 year earlier. Therefore, the management was only conservative, without surgery, and the possibility of metastasis from the salivary malignancy was overlooked. Later, rapid growth of the metastatic tumor resulted in an emergency laparotomy. Abdominal metastases of the mesentery, omentum, and peritoneum were observed. The patient experienced postoperative complications and died of ARDS.

We described a case of salivary gland carcinosarcoma harboring an osteosarcomatous component with abdominal metastasis consisted entirely of the sarcomatous element. Awareness of the possibility of abdominal metastasis by the sarcomatous component of salivary carcinosarcoma may help in managing patients with a history of abdominal surgery.

Abbreviations

CT: 

Computed tomography

ARDS: 

Acute respiratory distress syndrome

Declarations

Availability of data and materials

All findings of this case report are based on diagnostic examinations performed during patient hospitalization. The publication of these data was authorized by Chungbuk National University Hospital. Data sharing is not applicable to this article as no datasets were generated or analyzed in the present report.

Authors’ contributions

CGW wrote the original manuscript. SMS interpreted the pathological findings and revised the final manuscript. Both authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Institutional Review Board of Chungbuk National University Hospital (2018-02-016).

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pathology, Chungbuk National University Hosipital, 776, 1Sunhwan-ro, Seowon-gu, Cheongju, 28644, South Korea

References

  1. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(Pt 1):279–328.PubMedGoogle Scholar
  2. Stephen J, Batsakis JG, Luna MA, von der Heyden U, Byers RM. True malignant mixed tumors (carcinosarcoma) of salivary glands. Oral Surg Oral Med Oral Pathol. 1986;61:597–602.View ArticlePubMedGoogle Scholar
  3. Alvarez-Canas C, Rodilla IG. True malignant mixed tumor (carcinosarcoma) of the parotid gland. Report of a case with immunohistochemical study Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:454–8.View ArticlePubMedGoogle Scholar
  4. Harada H. Histomorphological investigation regarding to malignant transformation of pleomorphic adenoma (so-called malignant mixed tumor) of the salivary gland origin: special reference to carcinosarcoma. Kurume Med J. 2000;47:307–23.View ArticlePubMedGoogle Scholar
  5. Kwon MY, Gu M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: a case report and review of the literature. Arch Pathol Lab Med. 2001;125:812–5.PubMedGoogle Scholar
  6. Taki NH, Laver N, Quinto T, Wein RO. Carcinosarcoma de novo of the parotid gland: case report. Head Neck. 2013;35:E161–3.View ArticlePubMedGoogle Scholar
  7. Garner SL, Robinson RA, Maves MD, Barnes CH. Salivary gland carcinosarcoma: true malignant mixed tumor. Ann Otol Rhinol Laryngol. 1989;98:611–4.View ArticlePubMedGoogle Scholar
  8. Yamashita T, Kameda N, Katayama K, Hiruta N, Nakada M, Takeda Y. True malignant mixed tumor of the submandibular gland. Acta Pathol Jpn. 1990;40:137–42.PubMedGoogle Scholar
  9. Bleiweiss IJ, Huvos AG, Lara J, Strong EW. Carcinosarcoma of the submandibular salivary gland. Immunohistochemical findings. Cancer. 1992;69:2031–5.View ArticlePubMedGoogle Scholar
  10. de la Torre M, Larsson E. Fine-needle aspiration cytology of carcinosarcoma of the parotid gland: cytohistological and immunohistochemical findings. Diagn Cytopathol. 1995;12:350–3.View ArticlePubMedGoogle Scholar
  11. Carson HJ, Tojo DP, Chow JM, Hammadeh R, Raslan WF. Carcinosarcoma of salivary glands with unusual stromal components. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:738–46.View ArticlePubMedGoogle Scholar
  12. Gogas J, Markopoulos C, Karydakis V, Gogas G, Delladetsima J. Carcinosarcoma of the submandibular salivary gland. Eur J Surg Oncol. 1999;25:333–5.PubMedGoogle Scholar
  13. Sironi M, Isimbaldi G, Claren R, Delpiano C, Di Nuovo F, Spinelli M. Carcinosarcoma of the parotid gland: cytological, clinicopathological and immunohistochemical study of a case. Pathol Res Pract. 2000;196:511–7.View ArticlePubMedGoogle Scholar
  14. Mardi K, Sharma J. True malignant mixed tumor (carcinosarcoma) of parotid gland: a case report. Indian J Pathol Microbiol. 2004;47:64–6.PubMedGoogle Scholar
  15. Jang SM, Jun YJ, Han H, Jang KS, Paik SS. Parotid gland carcinosarcoma with osteosarcoma as a sarcomatous component: a case report with fine needle aspiration cytologic findings. Korean J Pathol. 2011;45:412–6.View ArticleGoogle Scholar
  16. Jha V, Kolte S, Goyal S, Mandal AK. Osteosarcoma arising in carcinosarcoma de novo parotid gland in a young man: an unusual case with review of literature. J Clin Diagn Res. 2017;11:ED08–10.PubMedPubMed CentralGoogle Scholar
  17. Owaki S, Kitano H, Hanada M, Asada Y, Sugihara H, Moritani S, Banba M. Carcinosarcoma of the submandibular gland: an autopsy case. Auris Nasus Larynx. 2003;30:439–42.View ArticlePubMedGoogle Scholar
  18. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas).Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20:277–85.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement